Skip to content
PubMed This is a summary of 50 peer-reviewed journal articles Updated

Research & Literature

Explore the leading researchers and institutions driving advances in this area, and dive into the full body of literature that informs this resource.

Explore the Literature Visualize citation networks across 50 referenced papers

Top Authors

Inga Zerr
German Center for Neurodegenerative Diseases
Liyong Wu
Capital Medical University
Roberto Chiesa
Mario Negri Institute for Pharmacological Research
Kexin Xie
Capital Medical University
Yue Cui
Capital Medical University
Min Kyung Chu
Capital Medical University
Brian S. Appleby
Case Western Reserve University
Matthias Schmitz
German Center for Neurodegenerative Diseases
Franc Llorens
Biomedical Research Networking Center on Neurodegenerative Diseases
Sonia M. Vallabh
Broad Institute

Top Institutions

Ranked by publications Top 10 institutions
02

Capital Medical University

Beijing, China

9 papers
08

Centre National de la Recherche Scientifique

Paris, France

12 papers

References

References (50)
  1. 1

    Preventive study in subjects at risk of fatal familial insomnia: Innovative approach to rare diseases.

    Forloni G, Tettamanti M, Lucca U, et al.

    Prion 2015; (9(2)):75-9 doi:10.1080/19336896.2015.1027857.

    PMID: 25996399
  2. 2

    Familial fatal insomnia with atypical clinical features in a patient with D178N mutation and homozygosity for Met at codon 129 of the prion protein gene.

    Sun L, Li X, Lin X, et al.

    Prion 2015; (9(3)):228-35 doi:10.1080/19336896.2015.1054601.

    PMID: 26074146
  3. 3

    Clinical, histopathological and genetic studies in a case of fatal familial insomnia with review of the literature.

    Peng B, Zhang S, Dong H, Lu Z

    International journal of clinical and experimental pathology 2015; (8(9)):10171-7.

    PMID: 26617725
  4. 4

    Identification of new molecular alterations in fatal familial insomnia.

    Llorens F, Thüne K, Schmitz M, et al.

    Human molecular genetics 2016; (25(12)):2417-2436 doi:10.1093/hmg/ddw108.

    PMID: 27056979
  5. 5

    Fatal Familial Insomnia: Clinical Aspects and Molecular Alterations.

    Llorens F, Zarranz JJ, Fischer A, et al.

    Current neurology and neuroscience reports 2017; (17(4)):30 doi:10.1007/s11910-017-0743-0.

    PMID: 28324299
  6. 6

    Clinical Features and Sleep Analysis of Chinese Patients with Fatal Familial Insomnia.

    Wu L, Lu H, Wang X, et al.

    Scientific reports 2017; (7(1)):3625 doi:10.1038/s41598-017-03817-3.

    PMID: 28620158
  7. 7

    Agrypnia excitata and obstructive apnea in a patient with fatal familial insomnia from China: A case report.

    Sun C, Xia W, Liu Y, et al.

    Medicine 2017; (96(49)):e8951 doi:10.1097/MD.0000000000008951.

    PMID: 29245265
  8. 8

    Fatal familial insomnia presenting with agrypnia excitata and very low atonia index level: A case report and literature review.

    Yang TW, Park B, Kim KT, et al.

    Medicine 2018; (97(18)):e0646 doi:10.1097/MD.0000000000010646.

    PMID: 29718878
  9. 9

    Fatal familial insomnia and sporadic fatal insomnia.

    Cracco L, Appleby BS, Gambetti P

    Handbook of clinical neurology 2018; (153()):271-299 doi:10.1016/B978-0-444-63945-5.00015-5.

    PMID: 29887141
  10. 10

    Case of fatal familial insomnia caused by a d178n mutation with phenotypic similarity to Hashimoto's encephalopathy.

    Stevens JM, Levine MR, Constantino AE, Motamedi GK

    BMJ case reports 2018; (2018()) doi:10.1136/bcr-2018-225155.

    PMID: 30012679
  11. 11

    Sporadic Fatal Insomnia in Europe: Phenotypic Features and Diagnostic Challenges.

    Abu-Rumeileh S, Redaelli V, Baiardi S, et al.

    Annals of neurology 2018; (84(3)):347-360 doi:10.1002/ana.25300.

    PMID: 30048013
  12. 12

    [Clinical, neuroimaging and genetic features of two Chinese families with fatal familial insomnia].

    Bian Y, Wang S, Han XC, et al.

    Zhonghua yi xue za zhi 2018; (98(31)):2501-2504 doi:10.3760/cma.j.issn.0376-2491.2018.31.010.

    PMID: 30139003
  13. 13

    Fatal familial insomnia and Agrypnia Excitata: Autonomic dysfunctions and pathophysiological implications.

    Baldelli L, Provini F

    Autonomic neuroscience : basic & clinical 2019; (218()):68-86 doi:10.1016/j.autneu.2019.02.007.

    PMID: 30890351
  14. 14

    Clinical features and genetic characteristics of two Chinese pedigrees with fatal family insomnia.

    He R, Hu Y, Yao L, et al.

    Prion 2019; (13(1)):116-123 doi:10.1080/19336896.2019.1617027.

    PMID: 31122137
  15. 15

    Age at onset in genetic prion disease and the design of preventive clinical trials.

    Minikel EV, Vallabh SM, Orseth MC, et al.

    Neurology 2019; (93(2)):e125-e134 doi:10.1212/WNL.0000000000007745.

    PMID: 31171647
  16. 16

    Antisense oligonucleotides extend survival of prion-infected mice.

    Raymond GJ, Zhao HT, Race B, et al.

    JCI insight 2019; (5()).

    PMID: 31361599
  17. 17

    Genetic Testing in Prion Disease: Psychological Consequences of the Decisions to Know or Not to Know.

    Schwartz M, Brandel JP, Babonneau ML, et al.

    Frontiers in genetics 2019; (10()):895 doi:10.3389/fgene.2019.00895.

    PMID: 31616476
  18. 18

    Diagnosis of prion diseases by RT-QuIC results in improved surveillance.

    Rhoads DD, Wrona A, Foutz A, et al.

    Neurology 2020; (95(8)):e1017-e1026 doi:10.1212/WNL.0000000000010086.

    PMID: 32571851
  19. 19

    Fatal familial insomnia: A new case description with early response to immunotherapy.

    Toribio-Díaz E, Quintas S, Peláez-Hidalgo A, et al.

    Journal of neuroimmunology 2020; (346()):577321 doi:10.1016/j.jneuroim.2020.577321.

    PMID: 32682141
  20. 20

    Stridor during sleep: description of 81 consecutive cases diagnosed in a tertiary sleep disorders center.

    Silva C, Iranzo A, Maya G, et al.

    Sleep 2021; (44(3)) doi:10.1093/sleep/zsaa191.

    PMID: 32954431
  21. 21

    Genetic prion disease: D178N with 129MV disease modifying polymorphism-a clinical phenotype.

    Tan TH, Stark RJ, Waterston JA, et al.

    BMJ neurology open 2020; (2(2)):e000074 doi:10.1136/bmjno-2020-000074.

    PMID: 33681799
  22. 22

    Fatal insomnia: the elusive prion disease.

    Patel D, Ibrahim H, Rankin J, et al.

    BMJ case reports 2021; (14(6)) doi:10.1136/bcr-2020-241289.

    PMID: 34158325
  23. 23

    Doxycycline rescues recognition memory and circadian motor rhythmicity but does not prevent terminal disease in fatal familial insomnia mice.

    Lavigna G, Masone A, Bouybayoune I, et al.

    Neurobiology of disease 2021; (158()):105455 doi:10.1016/j.nbd.2021.105455.

    PMID: 34358614
  24. 24

    Clinical profile of fatal familial insomnia: phenotypic variation in 129 polymorphisms and geographical regions.

    Zhang J, Chu M, Tian Z, et al.

    Journal of neurology, neurosurgery, and psychiatry 2022; (93(3)):291-297 doi:10.1136/jnnp-2021-327247.

    PMID: 34667102
  25. 25

    A fatal familial insomnia patient newly diagnosed as having depression: A case report.

    Yukang T, Jiaquan L, Xiaoling L, et al.

    Medicine 2021; (100(41)):e27544 doi:10.1097/MD.0000000000027544.

    PMID: 34731156
  26. 26

    A case of fatal familial insomnia: diagnostic and therapeutic approaches.

    Rose DK, Liu AJ

    Neurocase 2022; (28(1)):131-134 doi:10.1080/13554794.2021.2025249.

    PMID: 35037601
  27. 27

    Diagnostic accuracy of cerebrospinal fluid biomarkers in genetic prion diseases.

    Schmitz M, Villar-Piqué A, Hermann P, et al.

    Brain : a journal of neurology 2022; (145(2)):700-712 doi:10.1093/brain/awab350.

    PMID: 35288744
  28. 28

    Can insomnia be fatal? An Australian case of fatal familial insomnia.

    Habteslassie D, McMahon M, Wimaleswaran H

    Internal medicine journal 2022; (52(4)):667-670 doi:10.1111/imj.15737.

    PMID: 35419959
  29. 29

    Specific structuro-metabolic pattern of thalamic subnuclei in fatal familial insomnia: A PET/MRI imaging study.

    Xie K, Chen Y, Chu M, et al.

    NeuroImage. Clinical 2022; (34()):103026 doi:10.1016/j.nicl.2022.103026.

    PMID: 35504222
  30. 30

    Preventive pharmacological treatment in subjects at risk for fatal familial insomnia: science and public engagement.

    Forloni G, Roiter I, Artuso V, et al.

    Prion 2022; (16(1)):66-77 doi:10.1080/19336896.2022.2083435.

    PMID: 35737759
  31. 31

    Genetic counseling for prion disease: Updates and best practices.

    Goldman JS, Vallabh SM

    Genetics in medicine : official journal of the American College of Medical Genetics 2022; (24(10)):1993-2003 doi:10.1016/j.gim.2022.06.003.

    PMID: 35819418
  32. 32

    Sleep architecture and sleep-disordered breathing in fatal insomnia.

    Pérez-Carbonell L, Muñoz-Lopetegi A, Sánchez-Valle R, et al.

    Sleep medicine 2022; (100()):311-346 doi:10.1016/j.sleep.2022.08.027.

    PMID: 36182725
  33. 33

    Genetic aspects of human prion diseases.

    Appleby BS, Shetty S, Elkasaby M

    Frontiers in neurology 2022; (13()):1003056 doi:10.3389/fneur.2022.1003056.

    PMID: 36277922
  34. 34

    Analysis of a large case series of fatal familial insomnia to determine tests with the highest diagnostic value.

    Kortazar-Zubizarreta I, Eraña H, Pereda A, et al.

    Journal of neuropathology and experimental neurology 2023; (82(2)):169-179 doi:10.1093/jnen/nlac113.

    PMID: 36458954
  35. 35

    Dysfunction of the cardiac parasympathetic system in fatal familial insomnia: a heart rate variability study.

    Cui Y, Huang Z, Chu M, et al.

    Sleep 2023; (46(4)) doi:10.1093/sleep/zsac294.

    PMID: 36472576
  36. 36

    Clinical profiles and ethnic heterogeneity of sporadic fatal insomnia.

    Chen Z, Chu M, Zhang J, et al.

    European journal of neurology 2023; (30(4)):813-822 doi:10.1111/ene.15676.

    PMID: 36617541
  37. 37

    From parasomnia to agrypnia excitata - An illustrative case on diagnostic approach.

    Fong SL, Dy Closas AMF, Lim TT, et al.

    Parkinsonism & related disorders 2023; (109()):105332 doi:10.1016/j.parkreldis.2023.105332.

    PMID: 36948111
  38. 38

    [Fatal Familial Insomnia With Significant Correlations Between Involuntary Movements and Postural Changes:Report of One Case].

    Zhang L, Sun H, Zhang SM, et al.

    Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae 2024; (46(1)):135-138 doi:10.3881/j.issn.1000-503X.15589.

    PMID: 38433643
  39. 39

    [Clinical characteristics and diagnostics of human spongiform encephalopathies: an update].

    Hermann P, Goebel S, Zerr I

    Der Nervenarzt 2024; (95(4)):376-384 doi:10.1007/s00115-024-01644-2.

    PMID: 38503894
  40. 40

    Creutzfeldt-Jakob Disease and Fatal Familial Insomnia: Demographics and In-Hospital Mortality in Spain.

    Cuadrado-Corrales N, Lopez-de-Andres A, Hernández-Barrera V, et al.

    Journal of clinical medicine 2024; (13(15)) doi:10.3390/jcm13154401.

    PMID: 39124670
  41. 41

    Agrypnia excitata: a human model to explore the derailment of sleep-wake cycle integrated control.

    Mutti C, Baldelli L, Cortelli P, et al.

    Journal of sleep research 2025; (34(2)):e14324 doi:10.1111/jsr.14324.

    PMID: 39223838
  42. 42

    Fatal familial insomnia: Reporting a case of the rare nightmare.

    Hogue E, Weinberg D, Palecek E

    Journal of postgraduate medicine 2024; (70(4)):252-254 doi:10.4103/jpgm.jpgm_582_24.

    PMID: 39660573
  43. 43

    A fatal familial insomnia patient initially misdiagnosed as Alzheimer's disease: a case report.

    Qiao M, Wu H, Chi L, et al.

    BMC neurology 2024; (24(1)):489 doi:10.1186/s12883-024-03999-0.

    PMID: 39716111
  44. 44

    Fatal familial insomnia: A new case description with response to thoracic sympathetic nerve thermocoagulation and stellate ganglion block.

    Chen Y, Li Y, Zhou Y, et al.

    Sleep medicine 2025; (127()):24-27 doi:10.1016/j.sleep.2024.12.034.

    PMID: 39765140
  45. 45

    Clinical phenotype associated with A118V mutation of PRPN gene.

    Giannelli T, Ladogana A, Tiple D, et al.

    Journal of neurology 2025; (272(9)):635 doi:10.1007/s00415-025-13397-2.

    PMID: 40974405
  46. 46

    Pedigree analysis and genetic inheritance of fatal familial insomnia (FFI) in a Portuguese multigenerational family.

    Da Silva Correia A, Laginha I, Guimaraes S, et al.

    Journal of neurology 2025; (272(10)):706 doi:10.1007/s00415-025-13432-2.

    PMID: 41107634
  47. 47

    The Risk of Transmission of Genetic Prion Diseases is Greater Than 50.

    Kortazar-Zubizarreta I, Manero-Azua A, Eraña H, et al.

    European journal of neurology 2025; (32(12)):e70455 doi:10.1111/ene.70455.

    PMID: 41351309
  48. 48

    Genetic causes and modifiers of prion diseases.

    Mead S, Hermann P, Mok TH, et al.

    The Lancet. Neurology 2026; (25(2)):181-194 doi:10.1016/S1474-4422(25)00451-X.

    PMID: 41579904
  49. 49

    A Practice Framework for Genetic Testing in Asymptomatic Relatives of Patients With Creutzfeldt-Jakob Disease: Experience and Insights From Israel.

    Shir D, Bregman N, David AB, et al.

    European journal of neurology 2026; (33(6)):e70649 doi:10.1111/ene.70649.

    PMID: 42333775
  50. 50

    A sleep that never comes: Prions and their role in fatal familial insomnia - a literature review.

    Kalbarczyk W, Korczak K, Łysikowska M, et al.

    Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego 2026; (54(3)):368-374 doi:10.36740/Merkur202603117.

    PMID: 42435475